Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rankning i aktier #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aktiekurs
$64.97
Senast synkroniserad: 2024-05-20
Marknadsvärde
$1.97B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Kategori

Historik för aktiesplit för Alpine Immune Sciences, Inc. (ALPN)
Aktien Alpine Immune Sciences, Inc. (symbol: ALPN) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Jul 25, 2017.
En ALPN-aktie köpt före Jul 25, 2017 motsvarar nu 0.25 ALPN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2017-07-25 1:4 x0.25 x0.25
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH